Jane Street
AGTC

Jane Street’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Jane Street’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,936
Closed -$14K – 11392
2022
Q1 		$14K Sell
12,936
-384
-3% -$698 ﹤0.01% 10024
2021
Q4 		$25K Sell
13,320
-1,188
-8% -$2.85K ﹤0.01% 9751
2021
Q3 		$44K Sell
14,508
-24,468
-63% -$87.1K ﹤0.01% 9589
2021
Q2 		$152K Sell
38,976
-34,331
-47% -$142K ﹤0.01% 9042
2021
Q1 		$371K Buy
+73,307
New +$380K ﹤0.01% 7346
2020
Q3 		– Sell
-21,041
Closed -$117K – 8214
2020
Q2 		$117K Buy
+21,041
New +$96.4K ﹤0.01% 6656
2017
Q3 		– Sell
-12,064
Closed -$62K – 5245
2017
Q2 		$62K Buy
+12,064
New +$67.8K ﹤0.01% 4216

Other funds holding AGTC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jane Street's AGTC Position: Q2 2022 in Review

Jane Street sold out of Applied Genetic Technologies Corporation (AGTC) in Q2 2022, closing a stake of 12,936 shares — an estimated $14K sold.

Jane Street first reported a position in AGTC in Q2 2017 and held it in 7 quarters. The position peaked at $371K in Q1 2021. 47 funds tracked by Wall St. Rank hold AGTC as of Q2 2022.

  • Jane Street reported no remaining Applied Genetic Technologies Corporation position as of Q2 2022 after selling out during the quarter.
  • Jane Street sold 12,936 Applied Genetic Technologies Corporation shares in Q2 2022, an estimated $14K.
  • Jane Street first reported a position in Applied Genetic Technologies Corporation in Q2 2017 and held it in 7 quarters.
  • Jane Street's Applied Genetic Technologies Corporation position peaked at $371K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.